Area of research
Surgery · Cancer Research
Research interest
Research interests include Hepatocellular Carcinoma Treatment and Prognosis, Organ Transplantation Techniques and Outcomes, MicroRNA in disease regulation, and Cancer-related molecular mechanisms research.
A Universal Strategy of Anti-Tumor mRNA Vaccine by Harnessing "Off-the-Shelf" Immunity.
Thiostrepton suppresses intrahepatic cholangiocarcinoma progression via FOXM1-mediated tumor-associated macrophages reprogramming.
GPC3-based circular RNA vaccine suppresses hepatocellular carcinoma progression by activating adaptive immune responses.
Diverse RNA methylation patterns in neutrophils: key drivers in hepatocellular carcinoma.
Systemic chemotherapy improves outcome of hepatocellular carcinoma patients treated with transarterial chemoembolization.
Transarterial Chemoembolization With or Without Systemic Therapy for Unresectable Hepatocellular Carcinoma: A Retrospective Comparative Study.
A rare case of thymic carcinoma metastasize to liver.
IRGM is a novel regulator of PD-L1 via promoting S6K1-mediated phosphorylation of YBX1 in hepatocellular carcinoma.
Envafolimab plus lenvatinib and transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: a prospective, single-arm, phase II study.
Co-Delivery of siNRF2 and Sorafenib by a "Click" Dual Functioned Hyperbranched Nanocarrier for Synergistically Inducing Ferroptosis in Hepatocellular Carcinoma.
Deep learning nomogram for preoperative distinction between Xanthogranulomatous cholecystitis and gallbladder carcinoma: A novel approach for surgical decision.
Systematic pan-cancer analyses of the potential function of the Golgi scaffold protein PAQR3.
Risk factors for post-operative portal vein stenosis in pediatric liver transplantation: a single center case-control study.
Laparoscopic enucleation for pancreatic lipomatous hamartoma.
Chinese guidelines for minimally invasive donor hepatectomy in living donor liver transplantation (2024 edition).
Achieving laparoscopic anatomic resection for hepatocellular carcinoma by fluorescence guided positive staining of hepatic cone unit.
Amino acid metabolism in health and disease
Amino acid metabolism in health and disease.
Quality of Information in Gallstone Disease Videos on TikTok: Cross-sectional Study.
Mitochondrial TSPO Promotes Hepatocellular Carcinoma Progression through Ferroptosis Inhibition and Immune Evasion.
The efficacy and safety of cadonilimab combined with lenvatinib for first-line treatment of advanced hepatocellular carcinoma (COMPASSION-08): a phase Ib/II single-arm clinical trial
The efficacy and safety of cadonilimab combined with lenvatinib for first-line treatment of advanced hepatocellular carcinoma (COMPASSION-08): a phase Ib/II single-arm clinical trial.
N<sup>6</sup> -methyladenosine-modified circSTX6 promotes hepatocellular carcinoma progression by regulating the HNRNPD/ATF3 axis and encoding a 144 amino acid polypeptide.
First evidence of neonicotinoid insecticides in human bile and associated hepatotoxicity risk.
m<sup>6</sup>A-modification regulated circ-CCT3 acts as the sponge of miR-378a-3p to promote hepatocellular carcinoma progression.
Sintilimab Plus Modified FOLFIRINOX in Metastatic or Recurrent Pancreatic Cancer: The Randomized Phase II CISPD3 Trial.
MVI-TR: A Transformer-Based Deep Learning Model with Contrast-Enhanced CT for Preoperative Prediction of Microvascular Invasion in Hepatocellular Carcinoma.
Preoperative sintilimab plus transarterial chemoembolization for hepatocellular carcinoma exceeding the Milan criteria: A phase II trial.
USP35 promotes HCC development by stabilizing ABHD17C and activating the PI3K/AKT signaling pathway.
ST6GALNAC4 promotes hepatocellular carcinogenesis by inducing abnormal glycosylation.